FDA Inspection 1160392 — AbbVie Inc.
The FDA completed an inspection of AbbVie Inc. on Dec 15, 2021 in North Chicago, IL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Dec 15, 2021
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- North Chicago, IL (United States)
Additional Details
Sponsor, Contract Research Organization